The findings had been printed on-line Nov. 9 in JAMA Inside Medication.
The dangers to important employees in all disciplines who couldn’t earn a living from home had been clear from the start of the pandemic, mentioned Dr. Robert Glatter, an emergency medication doctor at Lenox Hill Hospital in New York Metropolis.
“However the danger of transmission to family members residing with important employees grew to become equally vital when contemplating potential for illness development together with neighborhood transmission,” Glatter mentioned.
Since scientists know that asymptomatic transmission of the virus is a serious means it spreads, steps like self-isolation and self-quarantining in separate rooms within the residence, together with sporting masks, may scale back the danger of transmission, he famous.
Another choice contains having important employees self-quarantine or self-isolate in resort rooms, which may considerably scale back the danger to family members, Glatter added.
“Family members who’re overweight, smoke, [are] older than 65, have diabetes, coronary heart illness, continual kidney illness, asthma or COPD are at a lot larger danger for hostile outcomes — together with demise — in the event that they contract COVID-19,” Glatter mentioned.
It is important to issue within the elevated danger to family members “when assessing total potential for neighborhood transmission and illness development of COVID-19 amongst important employees who cannot earn a living from home,” he confused.
Selden hopes these findings will assist policymakers when which are making choices concerning the economic system and public well being.
“To the extent that we will scale back the prevalence of COVID-19 in our communities via a mix of frequent sense, vigorous public well being and, finally, a vaccine, then we will scale back the extent to which policymakers have to decide on between the economic system and maintaining the inhabitants protected,” Selden mentioned.
For extra on COVID-19, head to the U.S. Centers for Disease Control and Prevention.
SOURCES: Thomas Selden, PhD, Heart for Financing, Entry and Price Developments, U.S. Company for Healthcare Analysis and High quality, Rockville, Md.; Robert Glatter, MD, emergency medication doctor, Lenox Hill Hospital, New York Metropolis; JAMA Inside Medication, Nov. 9, 2020, on-line